vs

Side-by-side financial comparison of Commerce.com, Inc. (CMRC) and Oncology Institute, Inc. (TOI). Click either name above to swap in a different company.

Oncology Institute, Inc. is the larger business by last-quarter revenue ($142.0M vs $89.5M, roughly 1.6× Commerce.com, Inc.). Oncology Institute, Inc. runs the higher net margin — -5.3% vs -9.3%, a 4.1% gap on every dollar of revenue. On growth, Oncology Institute, Inc. posted the faster year-over-year revenue change (41.6% vs 2.9%). Oncology Institute, Inc. produced more free cash flow last quarter ($2.2M vs $-2.2M). Over the past eight quarters, Oncology Institute, Inc.'s revenue compounded faster (22.5% CAGR vs 5.5%).

SPS Commerce, Inc. is a technology and application software company based in the United States that provides cloud-based supply chain management software. The company's headquarters are located in Minneapolis, Minnesota, but it also has a US office in New Jersey, and international locations in Amsterdam, Beijing, Breukelen, Hong Kong, Kyiv, Melbourne, Montpellier, Sydney, and Toronto.

Oncology Institute, Inc. is a specialized healthcare enterprise focused on delivering patient-centric, evidence-based oncology care services, including advanced treatment regimens, clinical trial access, and supportive care programs. It primarily operates across the United States, serving patients with diverse cancer diagnoses and partnering with care teams to improve treatment outcomes.

CMRC vs TOI — Head-to-Head

Bigger by revenue
TOI
TOI
1.6× larger
TOI
$142.0M
$89.5M
CMRC
Growing faster (revenue YoY)
TOI
TOI
+38.7% gap
TOI
41.6%
2.9%
CMRC
Higher net margin
TOI
TOI
4.1% more per $
TOI
-5.3%
-9.3%
CMRC
More free cash flow
TOI
TOI
$4.3M more FCF
TOI
$2.2M
$-2.2M
CMRC
Faster 2-yr revenue CAGR
TOI
TOI
Annualised
TOI
22.5%
5.5%
CMRC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CMRC
CMRC
TOI
TOI
Revenue
$89.5M
$142.0M
Net Profit
$-8.4M
$-7.5M
Gross Margin
78.3%
Operating Margin
-7.4%
-4.9%
Net Margin
-9.3%
-5.3%
Revenue YoY
2.9%
41.6%
Net Profit YoY
-250.0%
43.0%
EPS (diluted)
$-0.11
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CMRC
CMRC
TOI
TOI
Q4 25
$89.5M
$142.0M
Q3 25
$86.0M
$136.6M
Q2 25
$84.4M
$119.8M
Q1 25
$82.4M
$104.4M
Q4 24
$87.0M
$100.3M
Q3 24
$83.7M
$99.9M
Q2 24
$81.8M
$98.6M
Q1 24
$80.4M
$94.7M
Net Profit
CMRC
CMRC
TOI
TOI
Q4 25
$-8.4M
$-7.5M
Q3 25
$-2.2M
$-16.5M
Q2 25
$-8.4M
$-17.0M
Q1 25
$-353.0K
$-19.6M
Q4 24
$-2.4M
$-13.2M
Q3 24
$-7.0M
$-16.1M
Q2 24
$-11.3M
$-15.5M
Q1 24
$-6.4M
$-19.9M
Gross Margin
CMRC
CMRC
TOI
TOI
Q4 25
78.3%
Q3 25
78.4%
Q2 25
79.0%
Q1 25
79.4%
Q4 24
77.6%
Q3 24
76.3%
Q2 24
75.8%
Q1 24
77.1%
Operating Margin
CMRC
CMRC
TOI
TOI
Q4 25
-7.4%
-4.9%
Q3 25
-0.5%
-5.9%
Q2 25
-8.0%
-9.4%
Q1 25
-2.9%
-9.5%
Q4 24
-0.9%
-11.9%
Q3 24
-23.0%
-13.9%
Q2 24
-16.5%
-16.6%
Q1 24
-10.2%
-19.0%
Net Margin
CMRC
CMRC
TOI
TOI
Q4 25
-9.3%
-5.3%
Q3 25
-2.6%
-12.1%
Q2 25
-9.9%
-14.2%
Q1 25
-0.4%
-18.8%
Q4 24
-2.7%
-13.1%
Q3 24
-8.4%
-16.1%
Q2 24
-13.8%
-15.7%
Q1 24
-8.0%
-21.0%
EPS (diluted)
CMRC
CMRC
TOI
TOI
Q4 25
$-0.11
$-0.04
Q3 25
$-0.03
$-0.14
Q2 25
$-0.10
$-0.15
Q1 25
$0.00
$-0.21
Q4 24
$-0.03
$-0.14
Q3 24
$-0.09
$-0.18
Q2 24
$-0.15
$-0.17
Q1 24
$-0.08
$-0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CMRC
CMRC
TOI
TOI
Cash + ST InvestmentsLiquidity on hand
$141.1M
Total DebtLower is stronger
$157.0M
Stockholders' EquityBook value
$39.4M
$-15.7M
Total Assets
$308.8M
$164.7M
Debt / EquityLower = less leverage
3.99×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CMRC
CMRC
TOI
TOI
Q4 25
$141.1M
Q3 25
$142.0M
Q2 25
$134.5M
Q1 25
$120.7M
Q4 24
$178.2M
Q3 24
$168.4M
Q2 24
$275.8M
$9.9M
Q1 24
$265.2M
$29.8M
Total Debt
CMRC
CMRC
TOI
TOI
Q4 25
$157.0M
Q3 25
$157.3M
Q2 25
$157.5M
Q1 25
$157.8M
Q4 24
$216.5M
Q3 24
Q2 24
$340.9M
Q1 24
$340.5M
Stockholders' Equity
CMRC
CMRC
TOI
TOI
Q4 25
$39.4M
$-15.7M
Q3 25
$42.8M
$-12.3M
Q2 25
$38.8M
$-9.0M
Q1 25
$38.1M
$5.1M
Q4 24
$33.4M
$3.6M
Q3 24
$29.0M
$15.5M
Q2 24
$26.1M
$29.2M
Q1 24
$26.9M
$41.3M
Total Assets
CMRC
CMRC
TOI
TOI
Q4 25
$308.8M
$164.7M
Q3 25
$309.5M
$163.6M
Q2 25
$302.5M
$159.8M
Q1 25
$286.3M
$164.0M
Q4 24
$340.3M
$172.7M
Q3 24
$335.1M
$179.2M
Q2 24
$452.5M
$179.6M
Q1 24
$442.5M
$204.5M
Debt / Equity
CMRC
CMRC
TOI
TOI
Q4 25
3.99×
Q3 25
3.67×
Q2 25
4.06×
Q1 25
4.14×
Q4 24
6.49×
Q3 24
Q2 24
13.06×
Q1 24
12.65×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CMRC
CMRC
TOI
TOI
Operating Cash FlowLast quarter
$980.0K
$3.2M
Free Cash FlowOCF − Capex
$-2.2M
$2.2M
FCF MarginFCF / Revenue
-2.4%
1.5%
Capex IntensityCapex / Revenue
3.5%
0.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$16.9M
$-27.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CMRC
CMRC
TOI
TOI
Q4 25
$980.0K
$3.2M
Q3 25
$10.6M
$-12.6M
Q2 25
$13.6M
$-10.2M
Q1 25
$401.0K
$-5.0M
Q4 24
$12.4M
$4.2M
Q3 24
$5.6M
$819.0K
Q2 24
$11.7M
$-15.7M
Q1 24
$-3.4M
$-15.9M
Free Cash Flow
CMRC
CMRC
TOI
TOI
Q4 25
$-2.2M
$2.2M
Q3 25
$7.6M
$-13.2M
Q2 25
$11.9M
$-11.4M
Q1 25
$-424.0K
$-5.3M
Q4 24
$11.6M
$2.4M
Q3 24
$4.5M
$417.0K
Q2 24
$10.7M
$-17.5M
Q1 24
$-4.2M
$-16.5M
FCF Margin
CMRC
CMRC
TOI
TOI
Q4 25
-2.4%
1.5%
Q3 25
8.8%
-9.7%
Q2 25
14.1%
-9.5%
Q1 25
-0.5%
-5.1%
Q4 24
13.3%
2.4%
Q3 24
5.4%
0.4%
Q2 24
13.0%
-17.7%
Q1 24
-5.3%
-17.4%
Capex Intensity
CMRC
CMRC
TOI
TOI
Q4 25
3.5%
0.7%
Q3 25
3.4%
0.4%
Q2 25
2.0%
1.0%
Q1 25
1.0%
0.3%
Q4 24
0.9%
1.8%
Q3 24
1.3%
0.4%
Q2 24
1.3%
1.9%
Q1 24
1.0%
0.6%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CMRC
CMRC

Subscription And Circulation$65.2M73%
Partner And Services$24.4M27%

TOI
TOI

Other$82.1M58%
Fee For Service$36.3M26%
Capitated Revenue$23.6M17%

Related Comparisons